Company · CIK 0001855175 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Contineum Therapeutics, Inc. · CTNM
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 8, 2026 SForm 4 → | Sep 8, 6:08 pm EDT | Carmine N. StengoneCEO and President, Director | 2,500 | $16.46 | $41,142 | 17,217 | −12.7% | 10b5-1 |
| Sep 8, 2026 MForm 4 → | Sep 8, 6:08 pm EDT | Carmine N. StengoneCEO and President, Director | 2,500 | $1.01 | $2,525 | 19,717 | — | 10b5-1 |
| Aug 3, 2026 SForm 4 → | Aug 3, 6:14 pm EDT | Carmine N. StengoneCEO and President, Director | 2,500 | $16.01 | $40,029 | 17,217 | −12.7% | 10b5-1 |
| Aug 3, 2026 MForm 4 → | Aug 3, 6:14 pm EDT | Carmine N. StengoneCEO and President, Director | 2,500 | $1.01 | $2,525 | 19,717 | — | 10b5-1 |
| Jul 8, 2026 SForm 4 → | Jul 10, 5:20 pm EDT | Daniel S. LorrainChief Scientific Officer | 1,040 | $16.00 | $16,640 | 135,202 | −0.76% | 10b5-1 |
| Jul 8, 2026 MForm 4 → | Jul 10, 5:20 pm EDT | Daniel S. LorrainChief Scientific Officer | 1,040 | $1.01 | $1,050 | 135,227 | — | 10b5-1 |
| Jul 8, 2026 SForm 4 → | Jul 8, 6:49 pm EDT | Carmine N. StengoneCEO and President, Director | 2,500 | $16.00 | $40,000 | 17,217 | −12.7% | 10b5-1 |
| Jul 8, 2026 MForm 4 → | Jul 8, 6:49 pm EDT | Carmine N. StengoneCEO and President, Director | 2,500 | $1.01 | $2,525 | 19,717 | — | 10b5-1 |
| Jun 30, 2026 SForm 4 → | Jul 2, 5:47 pm EDT | Daniel S. LorrainChief Scientific Officer | 37,179 | $15.99 | $594,578 | 135,202 | −21.6% | 10b5-1 |
| Jun 30, 2026 MForm 4 → | Jul 2, 5:47 pm EDT | Daniel S. LorrainChief Scientific Officer | 33,009 | $1.01 | $33,339 | 143,555 | — | 10b5-1 |
| Jun 30, 2026 SForm 4 → | Jul 1, 7:04 pm EDT | Tim WatkinsCMO & Head of Development | 10,833 | $16.02 | $173,590 | 8,961 | −54.7% | 10b5-1 |
| Jun 30, 2026 MForm 4 → | Jul 1, 7:04 pm EDT | Tim WatkinsCMO & Head of Development | 10,833 | $4.50 | $48,749 | 19,794 | — | 10b5-1 |
| Jun 30, 2026 SForm 4 → | Jul 1, 7:04 pm EDT | Carmine N. StengoneCEO and President, Director | 10,000 | $16.01 | $160,080 | 17,217 | −36.7% | 10b5-1 |
| Jun 30, 2026 MForm 4 → | Jul 1, 7:04 pm EDT | Carmine N. StengoneCEO and President, Director | 10,000 | $1.07 | $10,725 | 27,217 | — | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 8, 2026 MForm 4 → | Sep 8, 6:08 pm EDT | Carmine N. StengoneCEO and President, Director | 2,500 | — | — | 274,430 | — | 10b5-1 |
| Aug 3, 2026 MForm 4 → | Aug 3, 6:14 pm EDT | Carmine N. StengoneCEO and President, Director | 2,500 | — | — | 276,930 | — | 10b5-1 |
| Jul 8, 2026 MForm 4 → | Jul 10, 5:20 pm EDT | Daniel S. LorrainChief Scientific Officer | 1,040 | — | — | 33,257 | — | 10b5-1 |
| Jul 8, 2026 MForm 4 → | Jul 8, 6:49 pm EDT | Carmine N. StengoneCEO and President, Director | 2,500 | — | — | 279,430 | — | 10b5-1 |
| Jun 30, 2026 MForm 4 → | Jul 2, 5:47 pm EDT | Daniel S. LorrainChief Scientific Officer | 33,009 | — | — | 34,297 | — | 10b5-1 |
| Jun 30, 2026 MForm 4 → | Jul 1, 7:04 pm EDT | Tim WatkinsCMO & Head of Development | 10,833 | — | — | 238,334 | — | 10b5-1 |
| Jun 30, 2026 MForm 4 → | Jul 1, 7:04 pm EDT | Carmine N. StengoneCEO and President, Director | 10,000 | — | — | 118,417 | — | 10b5-1 |
| Jun 26, 2026 AForm 4 → | Jun 26, 5:46 pm EDT | Gines Diego MirallesDirector | 19,000 | — | — | 19,000 | — | |
| Jun 26, 2026 AForm 4 → | Jun 26, 5:45 pm EDT | Lori Lyons-WilliamsDirector | 19,000 | — | — | 19,000 | — | |
| Jun 26, 2026 AForm 4 → | Jun 26, 5:44 pm EDT | Olivia C WareDirector | 19,000 | — | — | 19,000 | — | |
| Jun 26, 2026 AForm 4 → | Jun 26, 5:44 pm EDT | Evert B. SchimmelpenninkDirector | 19,000 | — | — | 19,000 | — | |
| Jun 26, 2026 AForm 4 → | Jun 26, 5:43 pm EDT | Troy A. IgnelziDirector | 19,000 | — | — | 19,000 | — | |
| Jun 26, 2026 AForm 4 → | Jun 26, 5:43 pm EDT | Todd R. BradyDirector | 19,000 | — | — | 19,000 | — | |
| Jun 26, 2026 AForm 4 → | Jun 26, 5:42 pm EDT | Sarah BoyceDirector | 19,000 | — | — | 19,000 | — |